# Momentum for a Thriving, Abundant Future!

Newsy: The Bright Side
Published: 2026-10-03T23:50:01.233Z
Source: https://newsyai.com/edition/28ccefd0-11e5-4ca5-88d8-70814a174a52
Archive: https://newsyai.com/newsy/dddcdfd1-ba63-4579-8b9c-883acd9f1fa5.md

---

**Good Morning, Optimist! October 3, 2026** 🌅

Humanity’s momentum toward engineered abundance keeps building with fresh milestones in fusion supply chains, policy support, and precision medicine, alongside inspiring conservation wins that show ecosystems rebounding under smart stewardship. These developments compound the progress we’ve seen, turning ambitious ideas into tangible steps forward—even amid ongoing global challenges. The future we’re shaping is one of abundance, resilience, and possibility.[[1]](https://thefusionreport.com/this-weeks-fusion-news-october-2-2026/)

## Clean Energy: Record HTS Orders, Policy Wins, and Scaling Milestones

Commonwealth Fusion Systems (CFS) secured a landmark order for more than 10,000 kilometers of high-temperature superconducting (HTS) tape from Japan’s Fujikura—the largest of its kind. This supply-chain breakthrough directly supports CFS’s ARC tokamak power plants, starting with the Fall Line Fusion Power Station in Virginia, bringing compact, high-field fusion closer to commercial reality.[[1]](https://thefusionreport.com/this-weeks-fusion-news-october-2-2026/)

California Governor Gavin Newsom signed SB 925 into law, directing the state to develop a strategic plan for fusion energy, including commercial strategies and in-state manufacturing support. This positions California as a leader in the global fusion race and pairs with broader U.S. legislative pushes like the American Leadership in Fusion Act.[[2]](https://sites.ucsd.edu/fpa/news/fusion-news/)

At the DIII-D National Fusion Facility, a multi-institutional team earned the American Physical Society’s John Dawson Award for advances in negative triangularity plasmas—configurations that deliver high confinement and stability, key for future reactors. Meanwhile, China’s ENN Group reported hydrogen-boron fusion reactions on its EXL-50U spherical torus, and the country’s BEST compact fusion device entered the engineering endgame.[[1]](https://thefusionreport.com/this-weeks-fusion-news-october-2-2026/)

On the solar side, researchers continue pushing boundaries with a new flexible perovskite record of 21.2% efficiency on PET substrates and certified large-area perovskite modules reaching 24% efficiency—advances that expand applications from building-integrated power to portable and space uses.[[3]](https://www.perovskite-info.com/prussian-blue-framework-pushes-perovskite-solar-cells-269-efficiency-holds-30)

These supply, policy, physics, and manufacturing gains show fusion and renewables accelerating in lockstep toward abundant clean energy.

## Gene Therapies: Firsts for Rare Diseases and Broader Access

The FDA approved Fayuvi (rebisufligene etisparvovec-hopf), the first gene therapy for pediatric patients with Sanfilippo syndrome type A (MPS IIIA). This one-time AAV9 treatment delivers a working copy of the SGSH gene, enabling enzyme production to reduce harmful buildup and offering the first disease-modifying option for this progressive neurodevelopmental disorder.[[4]](https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-pediatric-patients-sanfilippo-syndrome-type)

Ultragenyx’s Genglycos (pariglasgene brecaparvovec-opnr) received accelerated approval as the first gene therapy for glycogen storage disease type Ia (GSDIa) in patients aged 8 and older. The one-time AAV8 treatment targets the liver to express functional G6PC enzyme, significantly cutting reliance on cornstarch regimens that have long defined care for this rare metabolic condition.[[5]](https://www.pharmacytimes.com/view/fda-approves-first-gene-therapy-for-gsdia)

The FDA also expanded approval of Casgevy (exa-cel), the CRISPR-based therapy, to children as young as 2 years old with sickle cell disease or transfusion-dependent β-thalassemia—making it the first such gene-editing treatment available to this young age group and widening access to potentially curative options.[[6]](https://www.hcplive.com/view/fda-expands-exa-cel-casgevy-gene-therapy-approval-2-years-scd-b-thalassemia)

One-time genetic fixes are moving from promise to practice, rewriting outcomes for families facing rare diseases.

## Conservation: New Facilities and Thriving Rewilding Successes

Rajasthan Chief Minister Bhajanlal Sharma virtually inaugurated a new rewilding aviary at the Godawan Conservation and Breeding Centre in Ramdevra. This state-of-the-art facility strengthens captive breeding and rehabilitation efforts for the critically endangered Great Indian Bustard (Godawan), building directly on recent releases and supporting long-term population recovery in the wild.[[7]](https://www.newkerala.com/news/a/rajasthan-cm-virtually-inaugurates-rewilding-aviary-godawan-conservation-278.htm)

On Negros Island in the Philippines, the Talarak Foundation’s rewilding program has delivered remarkable results: five once-vanishing “West Visayan Big 5” species—including the Visayan spotted deer, warty pig, and several hornbills—are now successfully breeding in the wild at protected sites like the Bayawan Nature Reserve. Behaviors never before documented are emerging, and populations are thriving thanks to sustained captive breeding, releases, and habitat protection. The foundation’s work has earned international recognition, including partnership with the Global Rewilding Alliance.[[8]](https://happyeconews.com/rewilding-visayan-wildlife/)

Nature responds powerfully when we invest in breeding centers, protected releases, and ecosystem restoration—proof that biodiversity can recover and flourish.

## Momentum Toward Engineered Abundance

From CFS’s historic HTS tape order and California’s fusion strategy law to the first gene therapies for Sanfilippo syndrome type A and GSDIa, plus CRISPR access for younger patients, and the inauguration of a major bustard rewilding aviary alongside proven successes on Negros Island—these are not isolated events. They represent converging, compounding progress: private innovation meeting public policy, genetic tools maturing into reliable medicines, and conservation strategies delivering measurable ecological wins.

> “The best way to predict the future is to create it.” – Inspired by Peter Diamandis

Rise ready—the abundance we’re engineering is gaining speed every day! 🌍✨

**Sources** (for easy verification):  
- CFS HTS tape order & fusion roundups: The Fusion Report / OilPrice.com, October 1–3, 2026.  
- California SB 925 signing & DIII-D award: Fusion Power Associates / The Fusion Report, October 2–3, 2026.  
- ENN & BEST fusion updates: Industry reports, October 2026.  
- Flexible perovskite & large-module records: Perovskite-Info, October 1–3, 2026.  
- Fayuvi Sanfilippo approval: FDA press release, September 17, 2026 (reported October 2026).  
- Genglycos GSDIa approval: Pharmacy Times / BioPharm International, August–October 2026.  
- Casgevy age expansion: HCPLive, July–October 2026.  
- Godawan aviary inauguration: New Kerala / ANI / Indian reports, October 3, 2026.  
- Negros rewilding successes: Happy Eco News, October 2, 2026.  
- Additional context: Broader industry and conservation updates, September–October 2026.

Stay curious and optimistic—more good news tomorrow!
